Product Details: SUSTAVIRON-250 (Testosterone Blend Injection)

• Product Name: SUSTAVIRON-250

• Active Ingredient: Testosterone Blend (Typically a mix of short & long-acting esters, e.g., propionate, phenylpropionate, isocaproate, decanoate).

• Dosage: 250 mg per 1 mL ampoule.

• Form: Oil-based injectable solution (with disposable syringe included).

• Type: Anabolic-androgenic steroid (AAS).

• Manufacturer: Searle (now part of Pfizer).

Primary Uses:

1. Medical:

   • Testosterone replacement therapy (TRT) for hypogonadism.

   • Treatment of delayed puberty in males.

   • Hormone therapy for gender-affirming care (FTM).

2. Performance Enhancement (Off-label):

   • Bulking cycles (promotes muscle mass and strength).

   • Improves recovery, libido, and overall anabolism.

   • Often stacked with other AAS for synergistic effects.

Key Features:

• Blended Esters: Provides both fast-acting and sustained testosterone release (reduces injection frequency).

• High Bioavailability: Injectable form bypasses liver metabolism.

• Versatile: Suitable for TRT and performance goals.

Side Effects:

• Androgenic: Acne, hair loss, body/facial hair growth.

• Estrogenic: Water retention, gynecomastia (if aromatization is uncontrolled).

• Cardiovascular: Increased LDL cholesterol, blood pressure.

• Suppression: Natural testosterone shutdown (requires PCT post-cycle).

• Other: Mood swings, aggression, infertility (dose-dependent).

Administration:

• Typical Dosage (TRT): 250 mg every 2–3 weeks (medical use).

• Performance Dosage: 250–1000 mg/week (split into 2 injections).

• Injection Site: Intramuscular (glutes, thighs, deltoids).

Regulation:

• Prescription-Only in most countries.

• Banned in competitive sports (WADA/USADA).